TSO3 Sets Fourth Quarter and Full Year 2016 Earnings Call for Tuesday, March 21, 2017 at 10:30 a.m. EDT

Tuesday, March 7, 2017

 

Québec City, March 7, 2017 – TSO3 Inc. (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Tuesday, March 21, 2017, to discuss its financial results for the fourth quarter and full year ended December 31, 2016. Financial results will be issued in a press release prior to the call.

TSO3 President and CEO R.M. (Ric) Rumble and CFO Glen Kayll, will host the conference call, followed by a question and answer period.  

Date: Tuesday, March 21, 2017

Time: 10:30 a.m. Eastern Daylight Time (7:30 a.m. PDT)

Toll-free dial-in number: 1-888-231-8191

International dial-in number: 1-514-807-9895 (Montreal); 1-647-427-7450 (Toronto)

Conference ID: 1379182 

Analysts and institutional investors are invited to participate on the call. Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.   

Other interested parties may listen to the live webcast of the conference call at http://event.on24.com/r.htm?e=1379182&s=1&k=E0EFC15542DE35C9FC078DECC7B0B6F7

which will be available for replay in the Investors section of the Company’s website at www.tso3.com.   

About TSO3 

Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSOalso offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes. 

For more information about TSO3, visit the Company's web site at www.tso3.com.

- 30 -

Source: TSO3 Inc.

For further information

Company Contacts:

TSO3 Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com               

TSO3 Inc., Glen Kayll, CFO, Tel: 418 651-0003, Email: info@tso3.com

Investor Relations:  

Liolios Group, Inc., Scott Liolios, Tel: 949 574-3860, TOS@liolios.com

Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, bmire@renmarkfinancial.com

 

<  Back to News & Events